Patient preferences for treatment in relapsed/refractory acute leukemia

David Mott, Hannah Hussain, Jake Hitch, Sulayman Chowdhury, Samantha Nier and Chris Skedgel

Grant-Funded Research from Office of Health Economics

Abstract: When acute leukemia relapses, treatment decisions can be complex. Patients may face trade-offs between survival benefits, side effects and how treatment is delivered. This study asked people with acute leukemia across five countries what matters most to them when making these choices.

Keywords: Acute leukaemia; Preferences (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
Date: 2025-10-23
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.ohe.org/publications/patient-preferenc ... tory-acute-leukemia/ (text/html)
https://www.ohe.org/wp-content/uploads/2025/10/Mot ... -acute-leukemia-.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ohe:grafun:002522

Access Statistics for this paper

More papers in Grant-Funded Research from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).